Investor · MCLEAN, VA
Mark N. Larow
Open Mark in the network graph →Capital
$19.5M
across filings
Active
Mar 2016
to Mar 2025
Most-connected co-filers (49)
Rel N. Ambrozy · MCLEAN, VA12 sharedSteven E. Erickson · Hingham, MA10 sharedBen O. Dineen · Arlington, VA10 sharedDavid W. Anderson · Hingham, MA10 sharedOwen E. Burke · Los Angeles, CA10 sharedAnbec Capital Management, LLC · Hingham, MA9 sharedAnbec Advisors, LLC · Hingham, MA9 sharedSanju M. Bansal · McLean, VA9 sharedAndrew D. Bonanno · MOUNT KISCO, NY7 sharedSujatha Kannan · Highland, MD7 sharedKannan Rangaramanujam · Highland, MD7 sharedClaiborne Williams · Los Angeles, CA7 sharedJeffrey Cleland · San Carlos, CA7 sharedMelissa A. Mcgrane · Miami, FL6 sharedAhmed D. Wahla · MOUNT KISCO, NY6 sharedJustin Hanes · Baltimore, MD3 sharedJavier D. Saralegui · Las Vegas, NV3 sharedBarbara Slusher · Redwood City, CA3 sharedKristofer L. Medina · LOS ANGELES, CA3 sharedJohn J. Hong · Silver Spring, MD2 sharedKent N. Bennett · MCLEAN, VA2 sharedDamon D. Navarro · North Charleston, SC2 sharedDavid Harano · Silver Spring, MD2 sharedAlan Krafchin · Albany, NY2 shared Recent filings (20)
Anbec Partners, LPMar 2025 · 9 co-filersAnbec Partners, LPMar 2024 · 9 co-filersAnbec Partners, LPMar 2023 · 9 co-filersAnbec Partners, LPMar 2022 · 9 co-filersAshvattha Therapeutics, Inc.May 2021 · 16 co-filers$9.6MAnbec Partners, LPMar 2021 · 9 co-filersAnbec Partners, LPMar 2020 · 9 co-filersAshvattha Therapeutics, LLCMay 2019 · 13 co-filers$6.4MAnbec Partners, LPMar 2019 · 9 co-filersVerato, Inc.Jan 2019 · 17 co-filers$10.0MAshvattha Therapeutics, LLCJan 2019 · 11 co-filers$200KAshvattha Therapeutics, LLCJun 2018 · 8 co-filers$400KAnbec Partners, LPMar 2018 · 9 co-filersAnbec Partners, LPMar 2017 · 9 co-filersVerato, Inc.Dec 2016 · 17 co-filers$12.5MOrpheris, Inc.Jun 2016 · 11 co-filers$190Ashvattha Therapeutics, LLCJun 2016 · 11 co-filers$37KAshvattha Therapeutics, LLCMar 2016 · 11 co-filers$700KAnbec Partners, LPMar 2016 · 5 co-filersAraxid Prime, Inc.Jan 2015 · 13 co-filers$12.5MAraxid Prime, Inc.Jan 2015 · 13 co-filers$12.5M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →